Drug recall D-0580-2021
Product
Levalbuterol tartrate HFA Inhalation Aerosol 45 mcg/actuation 200 Metered Inhalations Net Contents: 15 g Rx Only NDC 0591-2927-54 Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA
Reason for recall
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lots and codes
200093
Recall details
- Recalling firm
- Cardinal Health Inc., Dublin, OH
- Quantity
- 828 inhalers
- Distribution
- FL, GA, SC
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 15, 2021
- Terminated
- June 17, 2024
Related products
- Levalbuterol tartrate HFA inhalation – drug information
- NDC 0591-2927 Levalbuterol tartrate HFA inhalation · Levalbuterol Tartrate 45 ug/1 · Actavis Pharma, Inc.